Office of Professional Education

Respiratory Medicine Updates: A Virtual Clinical Community

Next Session is February 16-17, 2022 • CME Credit for Zoom Webinar and Twitter Chat participants

Article: Sotatercept for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med 2021 Apr 1;384(13):1204-1215. doi: 10.1056/NEJMoa2024277.


  • Zoom Webinar with CME credit: REGISTER.
    • Wednesday, February 16, 2022
    • 11:30 am (PT) / 12:30 pm (MT) / 1:30 pm (CT) / 2:30 pm (ET)
    • 30-minutes
    • Expert faculty summarize a journal article and lead an academic and peer discussion with Q&A time.

  • Twitter Chat @NJHealthMedEd with CME credit: Add to Calendar
    • Thursday, February 17, 2022
    • 6:00 pm (PT) / 7:00 pm (MT) / 8:00 pm (CT) / 9:00 pm (ET)
    • 30-minutes
    • Expert faculty lead the Chat about the article summary to facilitate an academic and peer discussion with Q&A.
    • Go to Twitter, type in #PHTwitterJC and click on the “Latest” tab
    • Please use this hashtag when posting: #PHTwitterJC
    • Twitter Chat Instructions
    • Follow us on Twitter @NJHealthMedEd

Previous PH Journal Club Sessions:

  • November 17-18, 2021
    • November 2021 Article Summary: Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis. Can Respir J. 2021 Sep 1;2021:1626971. doi: 10.1155/2021/1626971. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • October 20-21, 2021
    • October 2021 Article Summary: Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2021 Jun 29. doi: 10.1164/rccm.202009-3698OC. Epub ahead of print. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • September 22-23, 2021
    • September 2021 Article Summary: A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated with Pulmonary Fibrosis, Chest. 2020 Aug; 158(2):637-645. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • August 18-19, 2021
    • August 2021 Article Summary: Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease, N Engl J Med. 2021;384(4):325-334. View here.
    • Recorded Zoom Webinar on VuMedi.

Target Audience:

Pulmonologists, Cardiologists, Rheumatologists, Primary Care and Internal Medicine Physicians, Physician Assistants, and Nurse Practitioners who treat patients with PH.

 

Program Chairs:

Patricia George, MD

Patricia George, MD
Associate Professor
Director, Pulmonary Hypertension Program
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health, Denver, CO

 
Mohammad Dalabih MD
Mohammad Dalabih, MBBS MHA
Assistant Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health, Denver, CO

 

Learning Objectives:

Upon completion of this activity, the participant will be better able to:

  • Utilize critical thinking and research analysis in the review of new data and guidelines in PH
  • Apply increased awareness and understanding of research, evidence and best practices to inform clinical practice in PH
  • Support an online community of practitioners to share key insights, latest research, and treatment strategies for patients with PH


Contact:

For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email proed@njhealth.org.

 

Accreditation and Designation Statements:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Webinars
National Jewish Health designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Twitter Chat Sessions
National Jewish Health designates each Other activity (social media discussion) for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support:

This activity is supported by an educational grant from United Therapeutics Corporation.